Alkem Laboratories Ltd - 539523 - Compliances-Reg.24(A)-Annual Secretarial Compliance
In terms of Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Annual Secretarial Compliance Report for the period ended 31st March, 2023 issued by Practising Company Secretary. Kindly take the same on record. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Please find enclosed herewith the transcript of the 'Q4 FY2023 Earnings Conference Call' which was hosted by the Company on Friday, 19th May, 2023. The said transcript shall also be made available on the website of the Company. Kindly take the same on record.
Alkem Laboratories Results Earnings Call for Q4FY23
Conference Call with Alkem Laboratories Ltd. Management and Analysts on Q4FY23 Performance and Outlook. Listen to the full earnings transcript. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the 'Q4FY23 and FY23 Earnings Conference Call' is available on the website of the Company at https://www.alkemlabs.com/earnings-call.php. Kindly take the same on records. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
With reference to our earlier communication dated 29.03.2017, the Company had entered into Amended and Restated Shareholders' Agreement dated 29.03.2017 ('Shareholders' Agreement'). The BOD of the Company at their meeting held today i.e. 19.05.2023 have approved the execution of amendment agreement to the Shareholders' Agreement ('Amendment Agreement') to include the Dhananjay and Madhurima Singh Trust , which was settled by Late Mr. Dhananjay Kumar Singh for the benefit of his family members, as a member to the Shareholders' Group II and to update the list of members in Shareholders' Group I and Shareholders' Group II to reflect the changes in the constituents thereof since the date of the Shareholders Agreement. It is to be noted that the execution of the said Amendment Agreement will not result in any effective change in management and control of the Company. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
The Board of Directors at its meeting held today i.e. 19th May, 2023, has, inter alia, approved the alteration of Articles of Association ('AOA') of the Company, subject to the approval of the shareholders at the ensuing Annual General Meeting, to include Dhananjay and Madhurima Singh Trust as a member of Shareholders' Group II and to update the list of members in Shareholders' Group I and Shareholders' Group II to reflect the changes in the constituents thereof since the date of the Amended and Restated Shareholders Agreement dated 29th March, 2017. Kindly take the same on record. Alkem Laboratories Ltd - 539523 - Closure of Trading Window
We refer to our earlier communication dated 27th March, 2023 regarding closure of trading window (for the purpose of financial results for the quarter and year ended 31st March, 2023) starting from 30th March, 2023 until the expiry of 48 hours after the date on which the Financial Results of the Company for the quarter and year ended 31st March, 2023 are communicated to the Stock Exchanges. The Financial Results of the Company for the quarter and year ended 31st March, 2023 having been communicated to the Stock Exchanges, today i.e. 19th May, 2023, the trading window shall open on 22nd May, 2023. Alkem Laboratories Ltd - 539523 - Closure of Trading Window
We refer to our earlier communication dated 27th March, 2023 regarding closure of trading window (for the purpose of financial results for the quarter and year ended 31st March, 2023) starting from 30th March, 2023 until the expiry of 48 hours after the date on which the Financial Results of the Company for the quarter and year ended 31st March, 2023 are communicated to the Stock Exchanges. The Financial Results of the Company for the quarter and year ended 31st March, 2023 having been communicated to the Stock Exchanges, today i.e. 19th May, 2023, the trading window shall open on 22nd May, 2023. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Investor Presentation
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q4FY23 and FY23 earnings and business updates and the same will be uploaded on the website of the Company. Kindly take note of the same.
